Dr. Hönle AG

XETRA HNL.DE

Dr. Hönle AG EBITDA for the year ending September 30, 2023: USD 511.78 K

Dr. Hönle AG EBITDA is USD 511.78 K for the year ending September 30, 2023, a -95.66% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Dr. Hönle AG EBITDA for the year ending September 30, 2022 was USD 11.80 M, a -27.27% change year over year.
Dr. Hönle AG EBITDA for the year ending September 30, 2021 was USD 16.22 M, a -6.60% change year over year.
Dr. Hönle AG EBITDA for the year ending September 30, 2020 was USD 17.37 M, a -21.13% change year over year.
Dr. Hönle AG EBITDA for the year ending September 30, 2019 was USD 22.02 M, a -43.81% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

XETRA: HNL.DE

Dr. Hönle AG

CEO	Dr. Markus Arendt
IPO Date	Jan. 24, 2001
Location	Germany
Headquarters	Nicolaus-Otto-Str. 2
Employees	573
Sector	Materials
Industries Chemicals & Advanced Materials

Description

Dr. Hönle AG supplies industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, medical technology, optics and opto electronics, automotive, and glass processing. The Equipment & Systems segment engages in the drying of inks and coatings, curing of adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.

Key trends

Past 5 years